Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Here's Why Shares in Johnson Controls Slumped Today (Hint: It's Nvidia Related)
Key PointsNvidia's next-generation AI infrastructure operates in a way that could potentially drive demand for Johnson Controls' products. Data centers' infrastructure is not Johnson Controls' core business, but it is a fast-growing area, and investors have high hopes for it. 10 stocks we like bette...
The Motley Fool
Wed, Jan 7
1 Stock I'd Buy Before Opendoor Technologies (OPEN) in 2026
Key PointsOpendoor stock skyrocketed last year as retail investors banded together to send it higher.It has a new CEO and a new direction, but there's plenty of ongoing risk.There are other disruptive tech companies that have long growth runways and are already profitable.10 stocks we like better th...
The Motley Fool
Wed, Jan 7
BofA Global Research downgrades M&T Bank to 'neutral'
BofA Global Research downgrades lender M&T Bank MTB.N to "neutral" from "buy"Stock down slightly premarket in thin trading; had hit 52-week high of $211.33 in previous session, about $10 shy of record highBofA expects limited catalysts to drive outperformance after a strong perio...
Reuters
Wed, Jan 7
Albertsons misses third-quarter revenue estimates
Jan 7 (Reuters) - Albertsons ACI.N missed Wall Street expectations for third-quarter revenue on Wednesday, hurt by stiff competition from larger rivals offering heavier holiday discounts.The company reported quarterly revenue of $19.1 billion, compared with estimates of $19.2 billion, according to d...
Reuters
Wed, Jan 7
This Was the Best Performing "Magnificent Seven" Stock in 2025 (Hint: Not Nvidia)
Key PointsNvidia has been among the biggest gainers over the past few years, thanks to strong demand for AI.While Alphabet has lagged its "Magnificent Seven" counterpart, it turned the tables in 2025, outpacing Nvidia.The resolution of the antitrust overhang, a strong AI showing, and a reasonable va...
The Motley Fool
Wed, Jan 7
Apogee Enterprises forecasts weak 2026 profit; shares slide
Shares of glass products makers Apogee Enterprises APOG.O fall 11.8% to $33 in premarket tradingCo forecasts FY26 profit below estimates, misses Q3 profit estSays FY26 profit forecast includes an unfavorable EPS impact of about 30 cents from tariffs Separately, co says CFO Matthew Osberg has resigne...
Reuters
Wed, Jan 7
Rezolute rises as drug shows promise for rare low blood sugar disorders
Shares of drug developer Rezolute RZLT.O rise 2.1% to $1.95 premarketCo says late-stage trial of ersodetug in congenital hyperinsulinism missed main goals but showed drug activityCongenital HI causes frequent severe drops in blood sugar; all 59 patients opted for extension study, RZLT saysSome child...
Reuters
Wed, Jan 7
Could Buying XRP Today Set You Up for Life?
Key PointsXRP hit a 52-week high of $3.65 in mid-2025, but still finished the year trading near $2.New spot XRP ETFs launched in November, paving the way for institutional investors to gain exposure to XRP.Further integration of XRP into the global financial system could help send it soaring in pric...
The Motley Fool
Wed, Jan 7
RPT-European stocks pause rally as traders assess Venezuela fallout ahead of data
Jan 7 (Reuters) - European stocks steadied on Wednesday after a streak of record closes, as investors took a breather to digest the latest U.S.-Venezuela developments ahead of a batch of fresh economic data.The STOXX 600 index .STOXX rose 0.1% by 0804 GMT, a day after notching a record closing high....
Reuters
Wed, Jan 7
Arrowhead Pharma slips after unveiling convertible, stock deals
Arrowhead Pharmaceuticals ARWR.O shares down 2.3% before the bell to $69.20 as co seeks capital Drug developer late Tues announced public offering of $500 mln 6-year convertible bonds (CBs) and $200 mln stock deal Co intends to use net proceeds from offerings for general purposes, including wo...
Reuters
Wed, Jan 7
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares
Key PointsSold 185,157 shares of BSCR; estimated trade size $3.65 million (based on average fourth-quarter 2025 price).Quarter-end position value declined by $3.37 million, reflecting both the sale and stock price effects.Transaction represented 1.46% of reportable AUM.Post-sale stake: 317,620 share...
The Motley Fool
Wed, Jan 7
CANADA STOCKS-TSX futures dip as investors weigh new US-Venezuela developments, key data in focus
Jan 7 (Reuters) - Futures linked to Canada's main stock index inched lower on Wednesday, after two consecutive sessions of record highs, as investors assessed new U.S.-Venezuela developments and awaited key economic data releases.March futures on Toronto's S&P/TSX Composite index SXFcv1 ...
Reuters
Wed, Jan 7
Can XRP Get Back to $3 in 2026?
Key PointsXRP's potential to transform global payments has made it one of the leading cryptocurrencies in the world.Last year saw the launch of multiple exchange-traded funds that make it easier to invest in XRP.Challenging market conditions, however, could weigh down the entire crypto market in 202...
The Motley Fool
Wed, Jan 7
Pre-Bell | S&P, Nasdaq Futures Inch Lower; Ventyx Biosciences Rockets 60%; Mobileye Surges 10%; Critical Metals Rises 8%; Precious Metals Shares Pull Back
01 Stock MarketAs of Jan 7, U.S. stock index futures are mixed, indicating a cautious tone before the opening bell. Dow futures edged higher, with the front contract up 0.04% at 49,741.00, while S&P 500 futures fell 0.07% to 6,982.75 and Nasdaq 100 futures fell 0.19% to 25,773. The setup suggests te...
Tiger News
Wed, Jan 7
Monte Rosa rises as heart drug shows promise in early-stage trial
Shares of drug developer Monte Rosa Therapeutics GLUE.O rise 18.6% to $19 premarketCo says its experimental pill, MRT-8102, sharply lowered inflammation in people at risk for heart disease in an early-stage trialCo's MRT-8102 cut inflammation marker CRP by 85% in high-risk patients, says coCRP i...
Reuters
Wed, Jan 7
LIVE MARKETS-UK housebuilders at a tipping point
STOXX 600 little changedDAX hits new recordEnergy, luxury stocks lagWall St futures lowerWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com UK HOUSEBUILDERS AT A TIPPING POINTUK hou...
Reuters
Wed, Jan 7
Hershey rises after Piper Sandler upgrades to 'overweight'
Shares of chocolate maker Hershey HSY.N rise 1.3% to $181.59 in premarket trading Piper Sandler upgrades stock to "overweight" from "neutral" ratingBrokerage says lower cocoa costs and the removal of tariffs give co more room to invest in growth and still raise profits faster than us...
Reuters
Wed, Jan 7
US STOCKS-S&P 500, Nasdaq futures inch lower after AI-driven rally; labor data in focus
Futures: Dow up 0.05%, S&P 500 down 0.09%, Nasdaq down 0.22%Strategy gains as MSCI keeps crypto treasury firms in indexesMobileye rises after $900 million deal for Mentee ADP's December data on private sector employment due at 8:15 a.m. ETBy Purvi Agarwal and Nikhil Sharma Jan 7 (Reuters)...
Reuters
Wed, Jan 7
U.S. STOCKS ON THE MOVE-Colgate, Strategy, AAR Corp
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8Futures linked to the S&P 500 and the Nasdaq inched lower on Wednesday, as investors took a pause after the S&P 500 and the Dow hit record highs in the previous session, while cautio...
Reuters
Wed, Jan 7
Prediction: Why Virgin Galactic Stock Is Set to Go to $0
Key PointsVirgin Galactic’s expenses are far outpacing its current revenues.Although management’s long-term model is impressive, it assumes flawless execution and very favorable luxury market conditions.While the company has succeeded in extending maturities with debt restructuring, it has increased...
The Motley Fool
Wed, Jan 7
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free